Schuler Jack W's Form 4 filing
YIELD10 Bioscience, Inc. (YTEN) · filed May 9, 2023
- Accession no.
- 0001175707-23-000122
- Filed
- May 9, 2023
- Trade date
- Dec 5-20, 2022
- Filing delay
- 155 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions. Open-market sales total $153.1K. It was filed 155 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Jack WCIK 0001021412 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | Common Stock | SSaleDisposed | −7,000 | $2.06 | −$14,420 | 701,858 | Indirect | |
| Dec 6, 2022 | Common Stock | SSaleDisposed | −7,000 | $1.96 | −$13,720 | 694,858 | Indirect | |
| Dec 7, 2022 | Common Stock | SSaleDisposed | −3,504 | $1.91 | −$6,692.64 | 691,354 | Indirect | |
| Dec 8, 2022 | Common Stock | SSaleDisposed | −5,300 | $1.91 | −$10,123 | 686,054 | Indirect | |
| Dec 9, 2022 | Common Stock | SSaleDisposed | −10,152 | $1.88 | −$19,085.76 | 675,902 | Indirect | |
| Dec 12, 2022 | Common Stock | SSaleDisposed | −4,292 | $1.80 | −$7,725.6 | 671,610 | Indirect | |
| Dec 13, 2022 | Common Stock | SSaleDisposed | −7,000 | $1.75 | −$12,250 | 664,610 | Indirect | |
| Dec 14, 2022 | Common Stock | SSaleDisposed | −18,192 | $1.89 | −$34,382.88 | 646,418 | Indirect | |
| Dec 15, 2022 | Common Stock | SSaleDisposed | −6,324 | $1.88 | −$11,889.12 | 640,094 | Indirect | |
| Dec 16, 2022 | Common Stock | SSaleDisposed | −7,000 | $1.82 | −$12,740 | 633,094 | Indirect | |
| Dec 19, 2022 | Common Stock | SSaleDisposed | −5,100 | $1.76 | −$8,976 | 627,994 | Indirect | |
| Dec 20, 2022 | Common Stock | SSaleDisposed | −608 | $1.78 | −$1,082.24 | 627,386 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.